SCHEMBL1614756

SCHEMBL1614756

Cc1nn2c(=O)cc(C(F)(F)F)[nH]c2c1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
LMNA P02545 3/20 0.50
HPGD P15428 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HSD17B10 Q99714 2/20 0.50
HTT P42858 1/20 0.50
PLAT P00750 1/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
MAPT P10636 2/20 0.40
MAPK1 P28482 1/20 0.40
POLB P06746 2/20 0.40
KCNQ3 O43525 2/20 0.39
KCNQ2 O43526 2/20 0.39
CREBBP Q92793 1/20 0.38
ALPL P05186 1/20 0.38
ALPI P09923 1/20 0.38
JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614785 0.88 MEN1 (0.46) KDM4ELMNAHPGDMEN1KMT2A
SCHEMBL1279157 0.86 ARF6 (0.47) KDM4ELMNAHPGDMEN1KMT2A
SCHEMBL1278706 0.85 KDM4E (0.44) KDM4ELMNAHPGDMEN1KMT2A
SCHEMBL1614504 0.81 ADORA2A (0.45) KDM4ELMNAHPGDMEN1KMT2A
SCHEMBL1614622 0.81 MAPT (0.53) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL1614110 0.81 KCNQ3 (0.45) KDM4ELMNAHPGDMEN1KMT2A
SCHEMBL1613643 0.81 KDM4E (0.41) KDM4ELMNAHPGDMEN1KMT2A
SCHEMBL13516426 0.80 MAPT (0.42) KDM4ELMNAHPGDMEN1KMT2A
SCHEMBL1279027 0.80 POLB (0.46) KDM4ELMNAHPGDMEN1KMT2A
SCHEMBL1279260 0.80 ARF6 (0.45) KDM4ELMNAHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 KDM4E 1364/4885LMNA 2076/4885HPGD 569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.